Equity Incentive Plan, Summary of Activity under 2024 Plan (Details) - Restricted Shares [Member] - 2024 Global Equity Incentive Plan [Member] - USD ($) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Nov. 18, 2024 |
Sep. 30, 2025 |
Mar. 31, 2025 |
|
| Number of restricted shares [Abstract] | |||
| Beginning balance (in shares) | 3,974,826 | ||
| Granted (in shares) | 4,884,030 | 0 | |
| Vested (in shares) | (2,696,442) | ||
| Ending balance (in shares) | 1,278,384 | 3,974,826 | |
| Exercisable or convertible, end of year (in shares) | 0 | ||
| Weighted average grant date fair value [Abstract] | |||
| Beginning balance (in dollars per share) | $ 3.23 | ||
| Granted (in dollars per share) | 0 | ||
| Vested (in dollars per share) | 3.2 | ||
| Ending balance (in dollars per share) | 3.27 | $ 3.23 | |
| Exercisable or convertible, end of year (in dollars per share) | $ 0 | ||
| Weighted average remaining life (in years) [Abstract] | |||
| Outstanding, weighted average remaining contractual life | 7 months 17 days | 10 months 17 days | |
| Aggregate intrinsic value [Abstract] | |||
| Outstanding, aggregate intrinsic value | $ 3,220,027 | $ 9,894,439 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested equity instruments other than options outstanding as of the balance sheet date can be currently converted or exercisable under the option plan. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at exercisable or convertible date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|